Sunday, August 2, 2026

JPi Healthcare’s DRE Duo: FDA Approval Opens Doors to the U.S. Market

JPi Healthcare launches its DRE Duo digital X-ray system in the U.S., enhancing global expansion and targeting international markets.

KT’s New Era: How CEO Park Yoon-young Plans to Transform the Company into an AI-Driven AX Platform

Park Yoon-young becomes KT's CEO, aiming to transform the company into an AI-focused AX Platform with strong growth and security.

Kim Jong Un Gears Up for Big Policy Reveal — Will He Reach Out to Trump?

North Korea's upcoming plenary meeting may signal new diplomatic messages amid leadership changes in the U.S. and South Korea.

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.
Latest

SK Biopharm CEO Lee Dong-hoon: “AI and open innovation are key to drug development” [BIO USA]

SK Biopharmaceuticals focuses on open innovation and AI for drug development, aiming to enhance CNS therapies and expand into new modalities.

Supply Chains, M&A and AI: As China Closes In, K-Bio Faces a Critical Window of Opportunity [BIO USA]

Korea's biotech industry faces challenges and opportunities amid global restructuring, emphasizing AI and support for startups at BIO USA 2026.

BIO International Convention 2026: How K-Bio is Shaping the Global Bioindustry

The BIO International Convention 2026 in San Diego showcases biotech innovation, with a focus on AI integration and global partnerships.

How Samsung’s Galaxy Watch and Alcedis are Revolutionizing Clinical Research with Real-World Data

Samsung Electronics partners with Alcedis to use Galaxy Watch data for drug development, enhancing clinical trials with wearable tech.

Understanding Vocal Polyps: Causes, Symptoms, and Treatment Options for 2026

A lecturer suffered vocal cord polyps due to excessive voice use. Symptoms include hoarseness and difficulty speaking. Treatment varies.

9-Year-Old Siamese Cat’s Life-Saving Surgery: How a Massive Tumor Was Successfully Removed

A 9-year-old cat named Tini underwent successful surgery to remove a massive stomach tumor, now recovering with chemotherapy.

Mexico Recognizes South Korea’s MFDS: What This Means for Drug Approvals

Mexico recognizes South Korea's MFDS as a reference authority, streamlining drug approvals and enhancing market access for Korean firms.

3 Alarming Health Risks for 30-Somethings: How Prehypertension and Prediabetes Can Double Your Stroke Risk

A study reveals that young adults with prehypertension, prediabetes, and borderline dyslipidemia face increased heart attack and stroke risks.

PharmaResearch says AMWC appearance validates its standing as a global medical aesthetics company

PharmaResearch showcased its Rejuran aesthetic solutions at AMWC Korea 2026, winning an award and gaining global recognition in aesthetic medicine.

Drug Development Is Inherently Unprofitable, Biotech Industry Warns as Delisting Reform Looms

South Korea's biotech sector faces stricter delisting rules, raising concerns over innovation and funding for drug development.

New Hope for IPF Patients: How Jascayd is Revolutionizing Treatment in 2026

Jascayd offers new hope for idiopathic pulmonary fibrosis patients, slowing lung function decline with a novel mechanism of action.

How New Law Will Transform Human-Derived Fat into High-Value Bio-Materials

Human-derived fat, once medical waste, is now a valuable resource for biotech after new legislation allows its recycling for regenerative medicine.

Hyundai Bioscience’s Xafty Clears Genotoxicity Study, Supporting U.S. Phase 2 Respiratory Virus Trial Plans

Hyundai Bioscience's Xafty shows no genotoxicity in tests, aiding its Phase 2 trial plans for respiratory viral infections.

Shaperon’s Acquisition of Niztech Signals Convergence of Biotechnology and Medical Devices

Shaperon's acquisition of Niztech signals a strategic shift towards expanding into medical devices and consumer markets in healthcare.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.